![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-desktop-header-01gif-33629.gif)
![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-mob-header-01gif-17728.gif)
X
20
Shaanxi Dasheng Pharmaceutical Tech Co., Ltd. Xi’an Cn, based in China, is a pharmaceutical company.
One of their significant offerings is Moxifloxacin hydrochloride, supported by a 'Valid' Certificate of Suitability (CEP) with the number R0-CEP 2018-298 - Rev 00
This Chemical Type CEP, issued on September 23, 2020, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 2254 associated with this CEP further emphasizes